1.Hypersensitivity to urokinase;
2.Active internal bleeding;
3.Severe uncontrolled hypertension;
4.Recent intracranial or intraspinal surgery or trauma;
5.Intracranial neoplasm, arteriovenous malformation, or aneurysm;
6.Known bleeding diathesis;
7.History of cerebrovascular accident; [Micromedex]
懷孕分類
Pregnancy Category: B (FDA). [Micromedex]
哺乳分類
Breast Feeding:
Infant risk cannot be ruled out. [Micromedex]
副作用
劑量和給藥方法
Pulmonary embolism:
loading dose, 4400 international units/kg IV over 10 minutes (rate, 90 mL/hr), followed by a continuous infusion of 4400 international units/kg/hr IV for 12 hours (rate, 15 mL/hr), flush line at end of infusion; repeat dose as necessary. [Micromedex]
小兒調整劑量
Intra-arterial route:
Arterial thrombosis:
a)Ductus Arteriosus
1) A loading dose of urokinase 4000 units/kilogram given intravenously over 10 minutes, followed by a maintenance dose of 4000 units/kg/hour infusion for 6 hours has been shown to be successful in restoring arterial pulse with no sequelae;
b) Femoral Artery
1) A loading dose of 4000 units/kilogram (kg) over 30 minutes and a maintenance dose of 4000 units/kg/hour in 0.9% sodium chloride were used in one study.
Intrapleural route:
Pleural effusion
a) Study dosage: 20,000 international units via the thoracostomy tube and retained for 2 hours, 3 times daily increased chest tube drainage within 24 hours following instillatio.
Safety and efficacy in pediatric patients have not been established. [Micromedex]
腎功能調整劑量
Dosage in Renal Failure
A) No dosage adjustment is needed in patients with renal failure. [Micromedex]
肝功能調整劑量
N/A
安定性
1) Store urokinase powder at 2 to 8 degrees Centigrade.
2) Reconstituted urokinase is reported to be stable for 24 hours under refrigeration or at room temperature. [Micromedex]